2
Participants
Start Date
August 24, 2017
Primary Completion Date
August 6, 2018
Study Completion Date
August 6, 2018
Vortioxetine
Vortioxetine is a selective serotonin re-uptake inhibitor (SSRI), a common form of treatment for major depressive disorder.
the Massachusetts General Hospital, Boston
Collaborators (1)
Takeda
INDUSTRY
Massachusetts General Hospital
OTHER